Diabetic retinopathy, diabetic macular edema, and cardiovascular risk: the importance of a long-term perspective and a multidisciplinary approach to optimal intravitreal therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetic retinopathy, diabetic macular edema, and cardiovascular risk: the importance of a long-term perspective and a multidisciplinary approach to optimal intravitreal therapy
Authors
Keywords
-
Journal
ACTA DIABETOLOGICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-20
DOI
10.1007/s00592-019-01453-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of 6000 intravitreal dexamethasone implants
- (2019) Bindu Rajesh et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the ‘DR-Pro-DEX Study’
- (2018) Matias Iglicki et al. ACTA DIABETOLOGICA
- Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
- (2018) Catharina Busch et al. ACTA DIABETOLOGICA
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review
- (2018) Ian Pearce et al. DIABETES OBESITY & METABOLISM
- Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
- (2018) Claudio Bucolo et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure
- (2017) Xiao-Rong Zhu et al. MEDICINE
- Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
- (2017) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGICA
- SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
- (2017) Robert L. Avery et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Dexamethasone Intravitreal Implant for Diabetic Macular Edema During Pregnancy
- (2016) Michael Concillado et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes
- (2016) Rong Chen et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
- (2016) David G. Callanan et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2016) John A. Wells et al. OPHTHALMOLOGY
- Anti–Vascular Endothelial Growth Factor Therapy in Pregnancy
- (2016) Zuhair H. Peracha et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY
- (2016) Raj K. Maturi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
- (2016) Pedro Romero-Aroca et al. Journal of Diabetes Research
- Systemic Safety of Prolonged Monthly Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
- (2016) Robert L. Avery et al. JAMA Ophthalmology
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective
- (2015) Tomas Jernberg et al. EUROPEAN HEART JOURNAL
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2015) David M. Brown et al. OPHTHALMOLOGY
- Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy
- (2014) Rafael Simó et al. DIABETES CARE
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2014) Jean-François Korobelnik et al. OPHTHALMOLOGY
- Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
- (2014) David S. Boyer et al. OPHTHALMOLOGY
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
- (2013) David M. Brown et al. OPHTHALMOLOGY
- Intraocular Pressure Monitoring Post Intravitreal Steroids: A Systematic Review
- (2013) Weerawat Kiddee et al. SURVEY OF OPHTHALMOLOGY
- Dysglycaemia, vasculopenia, and the chronic consequences of diabetes
- (2013) Hertzel C Gerstein et al. Lancet Diabetes & Endocrinology
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Trabecular Meshwork and Lens Partitioning of Corticosteroids
- (2011) Ashish Thakur et al. ARCHIVES OF OPHTHALMOLOGY
- Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes: Meta-analysis of observational studies
- (2011) C. K. Kramer et al. DIABETES CARE
- The RESTORE Study
- (2011) Paul Mitchell et al. OPHTHALMOLOGY
- Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal Insert
- (2010) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Adverse effects of anticancer agents that target the VEGF pathway
- (2009) Helen X. Chen et al. Nature Reviews Clinical Oncology
- Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk
- (2008) Tina Ken Schramm et al. CIRCULATION
- Pharmacokinetic Study of Dexamethasone Disodium Phosphate using Intravitreal, Subconjunctival, and Intravenous Delivery Routes in Rabbits
- (2008) Kamran Hosseini et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started